<DOC>
	<DOCNO>NCT00103298</DOCNO>
	<brief_summary>RATIONALE : Drugs use chemotherapy , melphalan , leucovorin , oxaliplatin , fluorouracil , work different way stop growth tumor cell , either kill cell stop divide . Giving one drug ( combination chemotherapy ) give drug different way may kill tumor cell . PURPOSE : This phase II trial study well isolate hepatic perfusion melphalan follow combination chemotherapy work treat patient unresectable liver metastasis colorectal cancer .</brief_summary>
	<brief_title>Isolated Hepatic Perfusion With Melphalan Followed Combination Chemotherapy Treating Patients With Unresectable Liver Metastases From Colorectal Cancer</brief_title>
	<detailed_description>OBJECTIVES : Primary - Determine response duration response patient previously untreated unresectable liver metastasis secondary colorectal cancer treat isolated hepatic perfusion melphalan follow leucovorin calcium , oxaliplatin , fluorouracil . Secondary - Determine pattern recurrence ( liver vs systemic ) patient treat regimen . - Determine progression-free overall survival patient treat regimen . - Correlate health-related quality life length survival patient treat regimen . OUTLINE : Patients undergo exploratory laparotomy . Patients evidence carcinomatosis previously visualize scan find surgical exploration remove study . All patient undergo isolate hepatic perfusion ( IHP ) . Once IHP establish , melphalan administer intra-arterially 3-5 minute circulate throughout liver 1 hour . Approximately 6-12 week later , patient receive systemic chemotherapy comprise oxaliplatin IV 2 hour day 1 leucovorin calcium IV 2 hour fluorouracil IV continuously 22 hour day 1-2 . Courses systemic chemotherapy repeat every 14 day 1 year absence disease progression unacceptable toxicity . Quality life assess baseline , laparotomy , completion systemic chemotherapy , every 6 month thereafter . After completion study treatment , patient follow every 3 month 1 year , every 3-4 month 2 year , every 6 month disease progression . PROJECTED ACCRUAL : A total 30 patient accrue study within 2-3 year .</detailed_description>
	<mesh_term>Colorectal Neoplasms</mesh_term>
	<mesh_term>Neoplasm Metastasis</mesh_term>
	<mesh_term>Oxaliplatin</mesh_term>
	<mesh_term>Fluorouracil</mesh_term>
	<mesh_term>Melphalan</mesh_term>
	<mesh_term>Levoleucovorin</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Histologically cytologically confirm colorectal cancer Metastatic disease limit parenchyma liver No evidence unresectable extrahepatic disease preoperative radiology Limited extrahepatic disease dominant lifelimiting liver disease allow provide extrahepatic site treatable local ablative measure ( e.g. , surgical resection external beam radiotherapy ) At least 40 % hepatic replacement tumor axial CT scan MRI Unresectable liver metastasis , define 1 follow : More 3 site disease liver Bilobar disease Tumor abut major vascular ductal structure Measurable disease Previously untreated disease PATIENT CHARACTERISTICS : Age 18 Performance status ECOG 02 Life expectancy Not specify Hematopoietic Hematocrit &gt; 27.0 % WBC &gt; 3,000/mm^3 Platelet count &gt; 100,000/mm^3 Hepatic Bilirubin &lt; 2.0 mg/dL PT &lt; 2 second upper limit normal Elevated transaminase level allow due liver metastases No cirrhosis biopsy No significant portal hypertension manifest follow : Ascites Esophageal varix endoscopy Significant collateral vessel around organ drain portal venous system radiography No chronic active hepatitis Hepatitis B C surface antigen negative No history venoocclusive disease Renal Creatinine ≤ 1.5 mg/dL OR Creatinine clearance &gt; 60 mL/min Cardiovascular No ischemic cardiac disease No history congestive heart failure LVEF &gt; 40 % echocardiogram stress thallium scan ( patient cardiac disease ) Pulmonary No chronic obstructive pulmonary disease chronic pulmonary disease Pulmonary function test ≥ 50 % predict ( patient pulmonary disease ) Other Not pregnant nursing Negative pregnancy test Fertile patient must use effective contraception Weight &gt; 30 kg No active infection No peripheral neuropathy ≥ grade 2 PRIOR CONCURRENT THERAPY : Biologic therapy Not specify Chemotherapy Prior adjuvant chemotherapy ( include leucovorin calcium , oxaliplatin , fluorouracil ) allow provide administer &gt; 6 month liver metastasis diagnose Endocrine therapy Not specify Radiotherapy More 4 week since prior radiotherapy malignancy recover Surgery Not specify Other No concurrent chronic anticoagulation therapy No concurrent immunosuppressive drug</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2006</verification_date>
	<keyword>recurrent colon cancer</keyword>
	<keyword>stage IV colon cancer</keyword>
	<keyword>recurrent rectal cancer</keyword>
	<keyword>stage IV rectal cancer</keyword>
	<keyword>liver metastasis</keyword>
</DOC>